News-Medical.Net on MSN
Tirzepatide reveals a brain signal that predicts returning food preoccupation
Researchers implanted electrodes in the human nucleus accumbens to track brain activity during severe food preoccupation in ...
A first-in-human study suggests that tirzepatide modulates abnormal activity in the brain’s nucleus accumbens, reducing food ...
New animal research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, ...
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as ...
News-Medical.Net on MSN
Brain recordings reveal short-lived effects of tirzepatide on food cravings
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the ...
GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...
Sponsored Content Retatrutide is a synthetic peptide, which research indicates functions as a triple agonist for type 2 diabetes and weight loss. Peptides, small chains of amino acids, have been ...
Participants who received tirzepatide, the active ingredient in Zepbound, also had greater reductions in waist size and more significant improvements in metabolic risk factors. Tirzepatide’s dual ...
Eli Lilly has shared positive results from a Phase II clinical trial (NCT06230523) evaluating eloralintide, an investigational once-weekly, selective amylin receptor, in adults with obesity or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results